Isn’t it funny…I took the complete opposite view that using Standard care (which changes over time) that by using our Rex-l in combination has this effect on top of Standard care and as such we were an adjunct so we were helping every drug now used and therefore not a threat to any big pharma and in fact that made us more attractive to partner with
Ann: DREAM HF Trial Published in JACC, page-64
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.175(9.83%) |
Mkt cap ! $1.909B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.58 | $6.461M | 3.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 34459 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 20739 | 5 |
View Market Depth
| Last trade - 11.43am 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |